Roche Holding AG


  • Roche 2013 sales fall but CEO confident Thursday, 30 Jan 2014 | 12:00 AM ET

    Global healthcare company Roche is confident of growth in emerging markets despite the economic slowdown.

  • Jan 13- Lexicon Pharmaceuticals Inc said its chief executive would leave and it would cut its workforce by about 45 percent, as it moves its focus away from drug discovery to completing the studies of its drugs in late-stage development. The company said Arthur Sands, CEO since 1995 and a co-founder, intends to develop a succession plan with the board.

  • Children's top flu medicine in short supply in U.S. Thursday, 9 Jan 2014 | 5:56 PM ET

    But the delay in packaging the liquid version has not affected supplies of regular Tamiflu, said the Roche unit that makes the medication.

  • Jan 9- In what is shaping up to be a tough and widespread flu season in the United States, one of the leading medicines used to treat children with the sometimes deadly virus is in short supply.

  • Private equity firm Carlyle Group is nearing an agreement to acquire a Johnson & Johnson unit, people familiar with the matter said.

  • European stocks close lower; Swiss stocks weigh Tuesday, 10 Dec 2013 | 11:50 AM ET

    European equities closed lower on Tuesday as investors remained cautious over the timing of the Fed's reduction of its stimulus program.

  • CHICAGO, Dec 9- There is a growing consensus that U.S. stocks, as well as stocks around the world, are going to catch a tailwind going into 2014.. The Vanguard Total World Stock Index ETF owns more than 5,000 stocks, but has its top holdings in mega-cap American companies like Apple Inc, Exxon Mobil Corp and Google Inc..

  • AbbVie leukemia drug impresses in early-stage trial Sunday, 8 Dec 2013 | 10:30 AM ET

    Dec 8- An experimental AbbVie Inc drug for leukemia controlled or eliminated signs of the disease in more than 80 percent of patients who had failed to benefit from previous treatments, an unprecedented finding that could spur use of the medicine for other cancers, researchers said.

  • Ohr aims big with eye drop to rival blockbusters Tuesday, 3 Dec 2013 | 10:42 AM ET

    Dec 3- Patients who are being treated for a leading cause of blindness among the elderly might be able to scale back on eye injections if trials confirm the potential of an eye drop being developed by a small New York- based company.

  • Drug compounding, tracking bill signed into U.S. law Wednesday, 27 Nov 2013 | 4:46 PM ET

    Nov 27- President Barack Obama signed a bill into law on Wednesday that gives U.S. health regulators greater oversight of bulk pharmaceutical compounding and strengthens their ability to track drugs through the distribution pipeline.

  • GSK's China sales topple on bribery scandal Wednesday, 23 Oct 2013 | 7:38 AM ET

    GlaxoSmithKline's pharmaceutical and vaccine sales to China tumbled 61 percent in the third quarter, with the drugmaker hit by an ongoing bribery investigation.

  • EU stocks close narrowly higher after debt deal Thursday, 17 Oct 2013 | 12:05 PM ET

    European equities closed narrowly higher on Thursday, with investors underwhelmed by U.S. lawmakers finally reaching a deal to lift the country's borrowing limit.

  • Roche looking to emerging markets for growth: CEO Thursday, 17 Oct 2013 | 1:21 AM ET

    Emerging markets still offer room for growth, Roche's CEO told CNBC after the pharma posted an 8 percent increase in third-quarter sales.

  • Now that that's over with, markets to focus on this Wednesday, 16 Oct 2013 | 10:17 PM ET

    With Washington's debt battle over, markets will quickly shift focus to earnings and how much the government shutdown actually impacted the economy.

  • Why Roche is launching a new investment plan     Monday, 14 Oct 2013 | 11:35 AM ET

    Andrew Weiss, head of pharma and biotech research at Vontobel, says Roche's plan reflects the Swiss pharmaceutical giant's strong pipeline.

  • Lufthansa signs record deal with Boeing, Airbus Thursday, 19 Sep 2013 | 11:58 AM ET

    German airline Deutsche Lufthansa announced its largest-ever aircraft order on Thursday, worth 14 billion euros ($19.0 billion).

  • Verizon prices record $49 billion bond sale Wednesday, 11 Sep 2013 | 2:05 PM ET

    Verizon Communications priced a massive bond sale on Wednesday, offering $49 billion worth of debt.

  • Studies back fast OK for Roche cancer drug: FDA Tuesday, 10 Sep 2013 | 1:58 PM ET

    The FDA is expected to decide on whether to fast track Perjeta for early treatment of breast cancer by Oct. 31.

  • Are drug companies giving up on heart research? Tuesday, 3 Sep 2013 | 12:50 PM ET

    As resources move to other areas, cardiologists fear the battle against heart disease could stall after advances marked by critical drugs to lower cholesterol and blood pressure.

  • Goldman sees 'creative destruction' in these trends Wednesday, 7 Aug 2013 | 7:51 PM ET

    The investment bank highlights eight industry themes it describes as "creative destruction" - trends that make it necessary for companies to either "adapt or die."

Most Popular Video

Wednesday, 16 Apr 2014 | 12:00 AM ET

GM unveils new models, hopes for strong sales this year After massive recalls, General Motors is pushing forward with new car models unveiled at the 2014 New York International Auto Show. CNBC's Phil LeBeau explains.

Friday, 11 Apr 2014 | 7:23 AM ET

Former Fed Chairman Ben Bernanke challenges Raghuram Rajan, Reserve Bank of India governor on his views about monetary policies, reports CNBC's Michelle Caruso-Cabrera.

Tuesday, 15 Apr 2014 | 5:40 PM ET

Jonathan Geller, BGR president and editor-in-chief, weighs in on the specifications for Amazon's newly announced 3-D smartphone.